| Issue |
Section |
Title |
File |
| Vol 78, No 6 (2003) |
Editorial |
Intradialysis hypotension: causes and sequelae |
|
| Vol 79, No 9 (2004) |
Editorial |
Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure |
|
| Vol 80, No 6 (2008) |
Editorial |
Nephroprotective role of early correction of impaired nutritional status in patients with chronic disease of the kidneys at a predialysis stage |
|
| Vol 85, No 6 (2013) |
Editorial |
New markers of cardio-renal links in chronic kidney disease |
|
| Vol 85, No 6 (2013) |
Editorial |
Phosphate binders in chronic kidney disease: The positions of sevelamer |
|
| Vol 86, No 4 (2014) |
Editorial |
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease |
|
| Vol 86, No 6 (2014) |
Editorial |
Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease |
|
| Vol 87, No 6 (2015) |
Editorial |
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease |
|
| Vol 88, No 4 (2016) |
Editorial |
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease |
(Rus)
|
| Vol 88, No 6 (2016) |
Editorial |
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection |
(Rus)
|
| Vol 88, No 6 (2016) |
Editorial |
Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs |
(Rus)
|
